The MIgGRATE Study will be evaluating options for adults with CIDP. Sign up for the WeConnect registry to be one of the first to be notified when the MIgGRATE Study goes live!
The CASCA Study will be evaluating options for adults with CIDP. Sign up for the WeConnect registry to be one of the first to be notified when the CASCA Study goes live!
Visit Takeda's Clinical Trials Transparency page to get in-depth information on all of Takeda's clinical research trials.
By joining WeConnect, you will be kept informed of trials that match your health needs so that you can have further conversations with your healthcare provider.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare neurological disorder that affects the nerves in the body. The nervous system, which includes the brain, spinal cord, and nerves, helps control movement and sensation. In CIDP, the immune system mistakenly attacks the protective covering of the nerves, called myelin. Myelin is important because it helps nerves send signals properly. When it is damaged, nerve signals slow down or get disrupted, leading to problems with movement, coordination, and feeling in different parts of the body.
The exact cause of CIDP is not fully understood, but it is believed to be an autoimmune disorder, meaning the body's immune system mistakenly attacks healthy nerve tissue. Researchers think a combination of genetic and environmental factors may play a role. In some cases, CIDP may be triggered by an infection or another illness that causes the immune system to overreact. While CIDP can affect people of all ages, it is more common in adults and is slightly more likely to occur in men than in women.
Doctors use different tests to diagnose CIDP. The process usually starts with a physical exam and a review of symptoms. Since CIDP symptoms can be like other nerve conditions, doctors may also order tests such as:
While there is no cure for CIDP, early treatment can help manage symptoms and slow disease progression. Treatment options may include:
CIDP can be a long-term condition, and symptoms may come and go over time. Some people have periods where they feel better, but symptoms can return. Weakness, numbness, and tingling in the arms and legs can make daily tasks difficult, such as walking, holding objects, or writing. Some people may also experience problems with balance and coordination. Physical therapy can help improve strength and movement, while occupational therapy can provide strategies for handling everyday activities. Support from family, friends, and healthcare providers is important in managing the challenges of CIDP.
Although there are treatments available for CIDP, responses to treatment can vary from person to person. Researchers are working to better understand CIDP and develop new therapies that can improve long-term outcomes. Clinical research is essential for advancing treatment options, and Takeda is committed to exploring innovative therapies to help people living with CIDP.
Your experience with CIDP is valuable. Take the next step in supporting CIDP research.
Sign up for our patient registry today. Together, we can make a difference.
Now, you can relax while we keep you updated with notifications about Takeda’s clinical trials that might be just the right fit for you.
We know you're interested in signing up for Takeda's WeConnect to get direct communication about Takeda clinical trials, but just in case you are looking for other ways to get involved – please review the information below.
BioLife Plasma Services is Takeda’s global plasma collection network and an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies that benefit thousands of people every day.
Learn more about plasma donation and how to help people who require life-saving plasma-based therapies by donating your plasma.
Our goal is to be readily available to support clinicians and researchers in whatever way we can. We believe the best way to improve disease outcomes is through robust and open communication about the science and clinical evidence.
That’s why we love to hear from medical professionals—to hear your questions, to understand what you’re seeing in the clinic, and to discuss research.